Phio Pharmaceuticals Appoints Robert M. Infarinato To The Position Of Vice President And CFO, Effective August 1, 2024
Portfolio Pulse from Benzinga Newsdesk
Phio Pharmaceuticals Corp. (NASDAQ:PHIO) has appointed Robert M. Infarinato as Vice President and CFO, effective August 1, 2024. Infarinato will oversee accounting, finance, treasury, investor relations, and administration.
August 01, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phio Pharmaceuticals has appointed Robert M. Infarinato as Vice President and CFO, effective August 1, 2024. Infarinato will be responsible for accounting, finance, treasury, investor relations, and administration.
The appointment of a new CFO can bring fresh perspectives and strategies to the company's financial management, potentially boosting investor confidence. Given Infarinato's responsibilities, his leadership could positively impact PHIO's financial health and investor relations.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100